Literature DB >> 2993936

Proteolytic activity in brains of rabbits treated with aluminum.

M Benuck, K Iqbal, H M Wisniewski, A Lajtha.   

Abstract

Aluminum injection in rabbits leads to neurofibrillary changes which are at light microscopic level similar to those found in Alzheimer's disease. We used this animal model to see whether changes in proteolytic activity occur that may affect protein degradation in the altered neurofibrillary structure. Rabbits were injected via the cisterna magna with aluminum chloride, and after ten days tissue was excised from the spinal cord, hippocampus, occipital lobe, and cerebellum. Sections from the hippocampus and spinal cord were examined for neurofibrillary changes; enzyme activity was measured in all four areas. The enzymes studied were cathepsins A, B, and D, and the angiotensin-converting enzyme. No significant differences could be established in enzymatic activity in aluminum-injected animals compared to controls. However, a significant decrease in Triton-soluble proteins was observed in the treated animals, which correlated with changes in neurofibrillary structure. This decrease was most noticeable in the spinal cord (from 16.6 to 12.5 mg/g).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2993936     DOI: 10.1007/bf00964531

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

1.  EXPERIMENTAL PRODUCTION OF NEUROFIBRILLARY DEGENERATION 2. ELECTRON MICROSCOPY, PHOSPHATASE HISTOCHEMISTRY AND ELECTRON PROBE ANALYSIS.

Authors:  R D TERRY; C PENA
Journal:  J Neuropathol Exp Neurol       Date:  1965-04       Impact factor: 3.685

2.  Purification and properties of brain cathepsin B. Evidence for cleavage of pituitary lipotropins.

Authors:  A Suhar; N Marks
Journal:  Eur J Biochem       Date:  1979-11-01

3.  Aluminium and Alzheimer's disease.

Authors:  J R McDermott; A I Smith; K Iqbal; H M Wisniewski
Journal:  Lancet       Date:  1977-10-01       Impact factor: 79.321

4.  Topography and dynamics of neurofibrillar degeneration in aluminum encephalopathy.

Authors:  H Wiśniewski; O Narkiewicz; K Wiśniewska
Journal:  Acta Neuropathol       Date:  1967-10-20       Impact factor: 17.088

5.  Alzheimer paired helical filaments: bulk isolation, solubility, and protein composition.

Authors:  K Iqbal; T Zaidi; C H Thompson; P A Merz; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

6.  Degradation of cytoskeletal proteins in experimental spinal cord injury.

Authors:  N L Banik; E L Hogan; J M Powers; L J Whetstine
Journal:  Neurochem Res       Date:  1982-12       Impact factor: 3.996

7.  Brain transglutaminase: in vitro crosslinking of human neurofilament proteins into insoluble polymers.

Authors:  D J Selkoe; C Abraham; Y Ihara
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

8.  Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination.

Authors:  W Cammer; B R Bloom; W T Norton; S Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

9.  Angiotensin converting enzyme in Alzheimer's disease increased activity in caudate nucleus and cortical areas.

Authors:  A Arregui; E K Perry; M Rossor; B E Tomlinson
Journal:  J Neurochem       Date:  1982-05       Impact factor: 5.372

10.  Observations on the effects of protease inhibitors on the suppression of experimental allergic encephalomyelitis.

Authors:  M E Smith; L A Amaducci
Journal:  Neurochem Res       Date:  1982-05       Impact factor: 3.996

View more
  1 in total

1.  Total and poly(A) RNA yields during an aluminum encephalopathy in rabbit brains.

Authors:  M F VanBerkum; Y L Wong; P N Lewis; D R Crapper McLachlan
Journal:  Neurochem Res       Date:  1986-09       Impact factor: 3.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.